aTYR PHARMA INC Contract Liability (Deferred Revenue)
aTYR PHARMA INC (ATYR) had Contract Liability (Deferred Revenue) of $53.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-24
- 2020-09-30: Contract with Customer, Liability, Current $53.00K.
- 2020-06-30: Contract with Customer, Liability, Current $201.00K.
- 2020-03-31: Contract with Customer, Liability, Current $143.00K.
- 2019-12-31: Contract with Customer, Liability, Current $208.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $53.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $201.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $143.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $208.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $352.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $536.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $630.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |